课题基金 / 基金详情

ZINC NEUROTOXICITY

ZINC NEUROTOXICITY
锌的神经毒性
批准号:
6738162
负责人:
CHRISTIAN Thomas SHELINE
金额:
$34.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-30 至 2007-03-31

项目摘要

项目成果

CHRISTIAN Thomas SHELINE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (From the Applicant's Abstract): Glutamate receptor- and Ca2+-mediated neurotoxicity was the focus of study during past grant periods. Recently, we have begun to examine a related form of neurotoxicity, also enhanced by glutamate receptor activation but mediated by Zn2+ rather than Ca2+. Zn2+-mediated neurotoxicity likely contributes to central neuronal death after certain insults, such as transient global ischemia. Our Central Hypothesis is that extracellular Zn2+ can kill neurons by: 1) entering across the plasma membrane, largely through voltage-gated Ca2+ channels (VGCCs) in depolarized neurons; 2) increasing intracellular free Zn2+ ([Zn2+]i); 3) interfering with glycolysis, causing ATP levels to fall; 4) triggering apoptosis (at lower Zn2+ levels). The proposed experiments will test aspects of this central hypothesis in cultured murine cortical neurons, delineating mechanisms underlying Zn2+-induced neuronal death to advance efforts to develop therapeutic countermeasures that might be used to reduce brain damage after cardiac arrest. Cultured neurons will be exposed to varying concentrations of extracellular zinc for brief ("fast toxicity") or prolonged ("slow toxicity") time periods. We plan to define the relationships linking transmembrane Zn2+ influx (measured with patch-clamp and radio-isotope flux techniques), [Zn2+]I (measured with dye videomacroscopy), cellular Zn2+ content (measured with atomic absorption spectroscopy or inductively-coupled plasma spectroscopy), and cellular apoptosis (v.s. necrosis). We will also measure resultant neuronal levels of ATP, NAD+, NADH and glycolytic intermediates, mitochondrial transmembrane potential, and cytoplasmic reactive oxygen species (measured with dihydroethidium dye). Finally, we will test genetic perturbations of cellular Zn2+ homeostasis, specifically increased or decreased expression of the key plasma membrane Zn2+ transporter, ZnT-1, or the major neuronal intracellular Zn2+ binding protein, metallothionein-III, will produce the changes in vulnerability to Zn2+ neurotoxicity predicted by the central hypothesis.
期刊论文(47)
专著(0)
科研奖励(0)
会议论文
Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo.
线粒体酶的辅因子可在体外和体内减轻铜诱导的死亡。
DOI: 10.1002/ana.10276
发表时间: 2002
期刊: Annals of neurology
影响因子: 11.2
作者: [Sheline,ChristianT, Choi,EricH, Kim-Han,Jeong-Sook, Dugan,LauraL, Choi,DennisW]
通讯作者: Choi,DennisW
DOI: 10.1016/s0079-6123(08)60767-0
发表时间: 1994
期刊: Progress in brain research
影响因子: --
作者: [D. Choi]
通讯作者: D. Choi
Sodium channel blockers reduce oxygen-glucose deprivation-induced cortical neuronal injury when combined with glutamate receptor antagonists.
钠通道阻滞剂与谷氨酸受体拮抗剂联合使用可减少氧糖剥夺引起的皮质神经元损伤。
DOI: --
发表时间: 1995
期刊: The Journal of pharmacology and experimental therapeutics.
影响因子: --
作者: [Lynch3rd,JJ, Yu,SP, Canzoniero,LM, Sensi,SL, Choi,DW]
通讯作者: Choi,DW
DOI: --
发表时间: 2000-06
期刊: Cellular and molecular biology
影响因子: 1.6
作者: [D. Lobner;L. Canzoniero;P. Manzerra;F. Gottron;H. Ying;M. Knudson;M. Tian;L. Dugan;G. Kerchner;C. Sheline;S. Korsmeyer;D. Choi]
通讯作者: D. Lobner;L. Canzoniero;P. Manzerra;F. Gottron;H. Ying;M. Knudson;M. Tian;L. Dugan;G. Kerchner;C. Sheline;S. Korsmeyer;D. Choi
17
    Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
    • 批准号:
      7998878
    • 项目类别:
    • 资助金额:
      $5.74万
    • 财政年份:
      2010
    • 负责人:
      CHRISTIAN Thomas SHELINE
    • 依托单位:
    Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
    • 批准号:
      7624970
    • 项目类别:
    • 资助金额:
      $26.42万
    • 财政年份:
      2006
    • 负责人:
      CHRISTIAN Thomas SHELINE
    • 依托单位:
    Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By Sirtuin-Mediated NAD+ Loss
    • 批准号:
      7393678
    • 项目类别:
    • 资助金额:
      $11.49万
    • 财政年份:
      2006
    • 负责人:
      CHRISTIAN Thomas SHELINE
    • 依托单位:
    Type-1 Diabetes: Zn2+ Potentiated Beta-Cell Death By
    • 批准号:
      7143563
    • 项目类别:
    • 资助金额:
      $31.26万
    • 财政年份:
      2006
    • 负责人:
      CHRISTIAN Thomas SHELINE
    • 依托单位:
    海外基金